Additional file 2 of Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)
2020-06-24T03:36:42Z (GMT) by
Additional file 2:. ESSENCE study site information. Presents study investigators, country, and patient numbers for all study sites.